{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T02:55:12Z","timestamp":1693968912825},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mop.0b013e328357a7c3","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T07:51:05Z","timestamp":1346831465000},"page":"592-602","source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis and management of sudden death in children"],"prefix":"10.1097","volume":"24","author":[{"given":"Frank A.","family":"Fish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prince J.","family":"Kannankeril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210206","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.hrthm.2009.07.046","article-title":"Population-based analysis of sudden death in children: the Oregon Sudden Unexpected Death Study.","volume":"6","author":"Chugh","year":"2009","journal-title":"Heart Rhythm"},{"key":"R2-8-20210206","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/hc4301.098254","article-title":"Sudden cardiac death in the United States, 1989 to 1998.","volume":"104","author":"Zheng","year":"2001","journal-title":"Circulation"},{"key":"R3-8-20210206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/CIRCULATIONAHA.106.658021","article-title":"Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.","volume":"115","author":"Arnestad","year":"2007","journal-title":"Circulation"},{"key":"R4-8-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2010.12.051","article-title":"Cardiac ion channel mutations in the sudden infant death syndrome.","volume":"152","author":"Klaver","year":"2011","journal-title":"Int Cardiol"},{"key":"R5-8-20210206","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome.","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"R6-8-20210206","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.hrthm.2011.11.006","article-title":"Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia.","volume":"9","author":"Murphy","year":"2012","journal-title":"Heart Rhythm"},{"key":"R7-8-20210206","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/europace\/euq460","article-title":"Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based approach.","volume":"13","author":"Hendrix","year":"2011","journal-title":"Europace"},{"key":"R8-8-20210206","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1542\/peds.2006-3751","article-title":"Contribution of inherited heart disease to sudden cardiac death in childhood.","volume":"120","author":"Hofman","year":"2007","journal-title":"Pediatrics"},{"key":"R9-8-20210206","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRSEHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"R10-8-20210206","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1161\/CIRCULATIONAHA.110.017228","article-title":"Screening for sudden cardiac death in the young: report from a National Heart, Lung, and Blood Institute Working Group.","volume":"123","author":"Kaltman","year":"2011","journal-title":"Circulation"},{"key":"R11-8-20210206","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/chi.0b013e318033ff59","article-title":"A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality.","volume":"46","author":"Satterfield","year":"2007","journal-title":"J Am Acad Child Psychiatry"},{"key":"R12-8-20210206","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","article-title":"Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficithyperactivity disorder corrected: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Defects Committee and the Council on Cardiovascular Nursing.","volume":"117","author":"Vetter","year":"2008","journal-title":"Circulation"},{"key":"R13-8-20210206","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.2008-1573","article-title":"Cardiovascular monitoring and stimulant drugs for attention deficithyperactivity disorder.","volume":"122","author":"Perrin","year":"2008","journal-title":"Pediatrics"},{"key":"R14-8-20210206","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0828-282X(09)70157-6","article-title":"Cardiac risk assessment before the use of stimulant medications in children and youth: a joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.","volume":"25","author":"Warren","year":"2009","journal-title":"Can J Cardiol"},{"key":"R15-8-20210206","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaac.2011.07.018","article-title":"Cardiovascular risk of stimulant treatment in pediatric attention-deficithyperactivity disorder: update and clinical recommendations.","volume":"50","author":"Hammerness","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R16-8-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12402-012-0072-8","article-title":"Heart rate variability and methylphenidate in children with ADHD.","volume":"4","author":"Buchhorn","year":"2012","journal-title":"Atten Defic Hyperact Disord"},{"key":"R17-8-20210206","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/appi.ajp.2009.09040472","article-title":"Sudden death and the use of stimulant medications in youths.","volume":"166","author":"Gould","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R18-8-20210206","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1542\/peds.2010-3371","article-title":"Cardiovascular events and death in children exposed and unexposed to ADHD agents.","volume":"127","author":"Schelleman","year":"2011","journal-title":"Pediatrics"},{"key":"R19-8-20210206","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults.","volume":"365","author":"Cooper","year":"2011","journal-title":"N Engl J Med"},{"key":"R20-8-20210206","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2011.1830","article-title":"ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.","volume":"306","author":"Habel","year":"2011","journal-title":"JAMA"},{"key":"R21-8-20210206","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.107.181423","article-title":"Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update - a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.","volume":"115","author":"Maron","year":"2007","journal-title":"Circulation"},{"key":"R22-8-20210206","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/eurheartj\/ehi108","article-title":"Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.","volume":"26","author":"Corrado","year":"2005","journal-title":"Eur Heart J"},{"key":"R23-8-20210206","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/JSM.0b013e3181b7332c","article-title":"The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes.","volume":"19","author":"Ljungqvist","year":"2009","journal-title":"Clin J Sport Med"},{"key":"R24-8-20210206","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7326\/0003-4819-152-5-201003020-00004","article-title":"Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study.","volume":"152","author":"Baggish","year":"2010","journal-title":"Ann Intern Med"},{"key":"R25-8-20210206","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.296.13.1593","article-title":"Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program.","volume":"296","author":"Corrado","year":"2006","journal-title":"JAMA"},{"key":"R26-8-20210206","first-page":"1291","article-title":"Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking J Am Coll C","volume":"57","author":"Steinvil","year":"2011","journal-title":"ardiol"},{"key":"R27-8-20210206","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2009.03.037","article-title":"Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.","volume":"104","author":"Maron","year":"2009","journal-title":"Am J Cardiol"},{"key":"R28-8-20210206","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.110.013078","article-title":"Interpretation of the electrocardiogram of young athletes.","volume":"124","author":"Uberoi","year":"2011","journal-title":"Circulation"},{"key":"R29-8-20210206","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.0000091380.04100.84","article-title":"ACCAHAESC guidelines for the management of patients with supraventricular arrhythmias: executive summary - a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).","volume":"108","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"Circulation"},{"key":"R30-8-20210206","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1542\/peds.111.3.e245","article-title":"Survey of current practice of pediatric electrophysiologists for asymptomatic Wolff-Parkinson-White syndrome.","volume":"111","author":"Campbell","year":"2003","journal-title":"Pediatrics"},{"key":"R31-8-20210206","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0735-1097(02)02706-7","article-title":"Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study.","volume":"41","author":"Pappone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R32-8-20210206","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJMoa040625","article-title":"Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome.","volume":"351","author":"Pappone","year":"2004","journal-title":"N Engl J Med"},{"key":"R33-8-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacc.2008.09.037","article-title":"The natural history of asymptomatic ventricular preexcitation a long-term prospective follow-up study of 184 asymptomatic children.","volume":"53","author":"Santinelli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R34-8-20210206","first-page":"59","article-title":"Asymptomatic ventricular preexcitation in children.","volume":"9","author":"Fazio","year":"2008","journal-title":"J Cardiovasc Med"},{"key":"R35-8-20210206","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.hrthm.2012.03.050","article-title":"PACESHRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS).","volume":"9","author":"Cohen","year":"2012","journal-title":"Heart Rhythm"},{"key":"R36-8-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCEP.110.958660","article-title":"Isoproterenol administration during general anesthesia for the evaluation of children with ventricular preexcitation.","volume":"4","author":"Moore","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R37-8-20210206","first-page":"97","article-title":"WPW pattern in the asymptomatic individual: has anything changed Circ Arrhythm E","volume":"2","author":"Klein","year":"2009","journal-title":"lectrophysiol"},{"key":"R38-8-20210206","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.111.048041","article-title":"Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to -blocker therapy in type 1 long-QT syndrome.","volume":"125","author":"Barsheshet","year":"2012","journal-title":"Circulation"},{"key":"R39-8-20210206","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/europace\/eur277","article-title":"Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.","volume":"14","author":"Van der Werf","year":"2012","journal-title":"Europace"},{"key":"R40-8-20210206","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.hrthm.2012.01.009","article-title":"Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective.","volume":"9","author":"Odening","year":"2012","journal-title":"Heart Rhythm"},{"key":"R41-8-20210206","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"R42-8-20210206","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1540-8159.2012.03421.x","article-title":"Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.","volume":"35","author":"Hong","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"R43-8-20210206","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/europace\/euq517","article-title":"Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.","volume":"13","author":"Pott","year":"2011","journal-title":"Europace"},{"key":"R44-8-20210206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/europace\/euq279","article-title":"Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia.","volume":"13","author":"Biernacka","year":"2011","journal-title":"Europace"},{"key":"R45-8-20210206","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R46-8-20210206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCEP.110.959916","article-title":"Inhibition of cardiac Ca2 release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.","volume":"4","author":"Hwang","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R47-8-20210206","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2011.03.038","article-title":"Long-term follow-up of patients with short QT syndrome.","volume":"58","author":"Giustetto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R48-8-20210206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hrthm.2010.09.073","article-title":"Pediatric ICD utilization in the United States from 1997 to 2006.","volume":"8","author":"Burns","year":"2011","journal-title":"Heart Rhythm"},{"key":"R49-8-20210206","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCFAHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary - a report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines.","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"R50-8-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2011.03.001","article-title":"Pharmacological and nonpharmacological management of the congenital long QT syndrome: the rationale.","volume":"131","author":"Schwartz","year":"2011","journal-title":"Pharmacol Ther"},{"key":"R51-8-20210206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10840-012-9665-6","article-title":"Subcutaneous chronic implantable defibrillation systems in humans.","volume":"34","author":"Cappato","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"R52-8-20210206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study.","volume":"23","author":"Gold","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R53-8-20210206","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/eurheartj\/ehs017","article-title":"Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution.","volume":"33","author":"Jarman","year":"2012","journal-title":"Eur Heart J"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e328357a7c3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:42:26Z","timestamp":1620963746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201210000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328357a7c3","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}